💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Idera Pharmaceuticals, Inc. (IDRA)
« Back to company indexIDRA Chatter Timeline
Stock Ticker for IDRA
Most Active Tweeters for IDRA
| User | Tweets |
|---|---|
| @FlashAlert_me | 12 |
| @InsiderAlerts4U | 6 |
| @fintel_io | 6 |
| @formwhisperscom | 5 |
| @usasingh1 | 3 |
Recent Tweets for IDRA
 |
@usasingh1 $IDRA PHASE 3 data by March 31- I loved it in 2015 and still like it https://t.co/Aj7x7Vhqwe 2:01am |
 |
@ZiadElkhalil @mazen_barbir $IDRA up 30% already since we last spoke ???? January 19th 2021, 10:01pm |
 |
@ShogunTrade $IDRA Trading is easy with Buy and Short signals https://t.co/PqVNTvw3t1 January 19th 2021, 10:01pm |
 |
@PMDiChristina Can’t hit the follow button for you!? Le Lounge $IDRA peat and repeat https://t.co/4ldJHVu9Ed January 19th 2021, 7:01pm |
 |
@bkfViking123 almost 200% gain on $idra January 19th 2021, 6:01pm |
 |
@LargeVoidBot 12:42 New 52wk Highs: $IDRA $STIM January 19th 2021, 5:01pm |
 |
@DatChiAfrican1 Added to $IDRA Illuminate-301 trial should hit the ORR and OS endpoints with a rolling NDA submission soon to follo… https://t.co/rqJC9j3H0q January 19th 2021, 5:01pm |
|
@usasingh1 $IDRA could be stock of the year 2021. U never know phase 3 soon @DanZanger January 19th 2021, 5:01pm |
|
@usasingh1 $IDRA Vol Alert options MAY 5 strike 2.00 January 19th 2021, 4:01pm |
 |
@Higgins14Steve $IDRA new 52 week high incoming January 19th 2021, 4:01pm |
 |
@MainSt_Bets 2K $IDRA May21 5.0 calls getting lifted for $2 January 19th 2021, 4:01pm |
|
@bkfViking123 $idra holding up well January 19th 2021, 2:01pm |
 |
@StckPro $IDRA NEW ARTICLE : Idera acquires API developer Apilayer https://t.co/pGNSpY2LPU Get all the latest $IDRA related… https://t.co/zuk7266GhZ January 18th 2021, 4:01pm |
 |
@MarketCurrents $IDRA - Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma https://t.co/QUJTyXo8UP January 13th 2021, 8:01pm |
 |
@FlashAlert_me $IDRA [15s. delayed] filed form 8-K on January 13, 08:05:35: Item7.01: Regulation FD https://t.co/dEtEDE6UF5 January 13th 2021, 1:01pm |
 |
@EdgarInsider A new filing Form 8-K [Press/News Current Report] has been made at the SEC by $IDRA $HBY #IderaPharmaceuticals, In… https://t.co/SyOVtA5LHl January 13th 2021, 1:01pm |
 |
@aistockfinder $IDRA https://t.co/84wtr2lcUN Idera Pharmaceuticals Inc. The statistical model is forecasting this equity has a neu… https://t.co/TSx3C1jBq6 January 13th 2021, 6:01am |
 |
@DeepSouthDoctor Not willing to make a bet on $IDRA pre-Q1 Ph3 data release. I think they have a shot at hitting PE, but see it as r… https://t.co/QcTCMS12sV January 13th 2021, 5:01am |
 |
@InsiderAlerts4U $IDRA: New Insider Filing on IDERA PHARMACEUTICALS, INC.'s Chief Financial Officer JOHN J. KIRBY: https://t.co/vQ6sJTt6J3 January 13th 2021, 3:01am |
|
@InsiderAlerts4U $IDRA: New Insider Filing on IDERA PHARMACEUTICALS, INC.'s Chief Medical Officer ELIZABETH ANN TARKA: https://t.co/Phd2tWBfX8 January 13th 2021, 3:01am |
|
@InsiderAlerts4U $IDRA: New Insider Filing on IDERA PHARMACEUTICALS, INC.'s SVP and General Counsel BRYANT DAVID LIM: https://t.co/5FLZzHkfBh January 13th 2021, 3:01am |
|
@InsiderAlerts4U $IDRA: New Insider Filing on IDERA PHARMACEUTICALS, INC.'s President & CEO VINCENT MILANO: https://t.co/JOk1G9cXgW January 13th 2021, 1:01am |
 |
@insiderbuyings $IDRA new insider selling: 1693 shares. https://t.co/yIPpOTuuEh January 13th 2021, 12:01am |
 |
@fintel_io Insider Kirby John J. reports selling 1,693 shares of $IDRA for a total cost of $7,151.74 https://t.co/kq6Fbe3ASQ January 13th 2021, 12:01am |
|
@FlashAlert_me $IDRA [15s. delayed] filed SEC form 4: Chief Financial Officer Kirby John J.: Disposed 1,693 of Common Stock at pr… https://t.co/R3B87EvVRu January 13th 2021, 12:01am |
 |
@formwhisperscom #FWSells $IDRA Kirby John J., Chief Financial Officer of IDERA PHARMACEUTICALS, INC. sold 1,693 shares on 2021-01-1… https://t.co/vRLPLCZVEP January 13th 2021, 12:01am |
|
@FlashAlert_me $IDRA [15s. delayed] filed SEC form 4: Chief Medical Officer Tarka Elizabeth Ann: Disposed 1,745 of Common Stock a… https://t.co/2yy3oXAQte January 13th 2021, 12:01am |
|
@formwhisperscom #FWSells $IDRA Tarka Elizabeth Ann, Chief Medical Officer of IDERA PHARMACEUTICALS, INC. sold 1,745 shares on 2021-… https://t.co/whyNg69EKn January 13th 2021, 12:01am |
|
@fintel_io Insider Elizabeth Ann Tarka reports selling 1,745 shares of $IDRA for a total cost of $7,309.80 https://t.co/g1WTdFR85H January 13th 2021, 12:01am |
|
@FlashAlert_me $IDRA [15s. delayed] filed SEC form 4: SVP and General Counsel Lim Bryant David: Disposed 1,711 of Common Stock at… https://t.co/jvK6kVr082 January 13th 2021, 12:01am |
|
@formwhisperscom #FWSells $IDRA Lim Bryant David, SVP and General Counsel of IDERA PHARMACEUTICALS, INC. sold 1,711 shares on 2021-0… https://t.co/xmYawlXuOi January 13th 2021, 12:01am |
|
@fintel_io Insider Bryant David Lim reports selling 1,711 shares of $IDRA for a total cost of $7,201.77 https://t.co/UN8Pd42XOv January 13th 2021, 12:01am |
|
@fintel_io Insider Vincent Milano reports selling 3,210 shares of $IDRA for a total cost of $13,474.30 https://t.co/0okZkuOd8Q January 13th 2021, 12:01am |
|
@FlashAlert_me $IDRA [15s. delayed] filed SEC form 4: President & CEO MILANO VINCENT: Disposed 3,210 of Common Stock at price $4.… https://t.co/AOdSgyksif January 13th 2021, 12:01am |
|
@formwhisperscom #FWSells $IDRA MILANO VINCENT, President & CEO of IDERA PHARMACEUTICALS, INC. sold 3,210 shares on 2021-01-12. https://t.co/iRey9K9VBo January 13th 2021, 12:01am |
 |
@1stOncology #IderaPharmaceuticals to Present at Upcoming Conferences $IDRA https://t.co/w0gjZQgDhx January 12th 2021, 8:01am |
|
@InsiderAlerts4U $IDRA: New Insider Filing on IDERA PHARMACEUTICALS, INC.'s President & CEO VINCENT MILANO: https://t.co/Bh3hNYceqH January 12th 2021, 4:01am |
|
@InsiderAlerts4U $IDRA: New Insider Filing on IDERA PHARMACEUTICALS, INC.'s SVP and General Counsel BRYANT DAVID LIM: https://t.co/guSZiT0SB3 January 12th 2021, 1:01am |
|
@insiderbuyings $IDRA new insider selling: 1465 shares. https://t.co/yIPpOTuuEh January 12th 2021, 1:01am |
|
@fintel_io Insider Bryant David Lim reports selling 1,465 shares of $IDRA for a total cost of $5,722.00 https://t.co/UN8Pd42XOv January 12th 2021, 1:01am |
|
@FlashAlert_me $IDRA [15s. delayed] filed SEC form 4: SVP and General Counsel Lim Bryant David: Disposed 1,465 of Common Stock at… https://t.co/RJb9ywJOhK January 12th 2021, 1:01am |
|
@FlashAlert_me $IDRA [15s. delayed] filed SEC form 4: President & CEO MILANO VINCENT: Disposed 2,740 of Common Stock at price $3.… https://t.co/lxCtq27Xa1 January 12th 2021, 1:01am |
|
@fintel_io Insider Vincent Milano reports selling 2,740 shares of $IDRA for a total cost of $10,699.97 https://t.co/0okZkuOd8Q January 12th 2021, 1:01am |
 |
@StockNewsNow $IDRA Idera Pharmaceuticals to Present at Upcoming Conferences https://t.co/4D7inmaUGU January 11th 2021, 6:01pm |
 |
@SmallCapsDaily $IDRA Idera Pharmaceuticals to Present at Upcoming Conferences GlobeNewswire https://t.co/KHHtyEIKwW… https://t.co/0VuWCS3oou January 11th 2021, 4:01pm |
 |
@MarcJacksonLA $IDRA Idera Pharmaceuticals to Present at Upcoming Conferences https://t.co/yD5bKmQaCd TG January 11th 2021, 2:01pm |
|
@StckPro $IDRA NEW ARTICLE : Idera Pharmaceuticals to Present at Upcoming Conferences https://t.co/yw49FjFzhR Get all the la… https://t.co/tWOIEU57hr January 11th 2021, 11:01am |
 |
@Beeken_health $IDRA - Idera Pharmaceuticals to Present at Upcoming Conferences https://t.co/Uq5lQCInZz https://t.co/RlxVH1051d January 11th 2021, 11:01am |
|
@EdgarInsider SEC Form 8-K [Press/News Current Report] filed by $IDRA $HBY #IderaPharmaceuticals, Inc https://t.co/abvM1mZsnD January 11th 2021, 11:01am |
|
@FlashAlert_me $IDRA [15s. delayed] filed form 8-K on January 11, 06:04:42: Item7.01: Regulation FD https://t.co/mSKjleO8s5 January 11th 2021, 11:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
